Clinical Trials · NCT05567796
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 3,400
- Start date
- Nov 2022
- Locations
- 254 sites, 23 countries
- Primary endpoint
- CagriSema versus placebo: Relative change in body weight